VIR
USDVir Biotechnology Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$5.460
고가
$5.520
저가
$5.200
거래량
1.66M
기업 기본 정보
시가총액
729.3M
산업
생명공학
국가
United States
거래 통계
평균 거래량
1.44M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025
Vir Biotechnology, Inc. (NASDAQ:VIR), today announced that the Company will provide a corporate update and report financial results for the third quarter ended September 30, 2025, on November 5, 2025. The Company will
Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTEN® Dual-Masked T-Cell Engager VIR-5500 in Combination with Androgen Receptor Pathway Inhibitors for the Treatment of Metastatic Prostate Cancer
– Phase 1 clinical trial designed to assess the safety, pharmacokinetics and preliminary efficacy of VIR-5500 in combination with androgen receptor pathway inhibitors in first-line mCRPC – Clinical trial builds on
Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD's The Liver Meeting® 2025
– Week 48 endpoint results from the SOLSTICE Phase 2 clinical study evaluating tobevibart alone or in combination with elebsiran for chronic hepatitis delta to be presented – Vir Biotechnology to showcase progress in
관련 주식
NOM
Nuveen Missouri Quality Municipal Income Fund
WTMAR
Welsbach Technology Metals Acquisition Corp. one right to receive 1/10th of a share of
NIM
Nuveen Select Maturities Municipal Fund
KRO
Kronos Worldwide Inc
MPB
Mid Penn Bancorp
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기